Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
about
Non-alcoholic fatty liver disease: what the clinician needs to know.Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse.Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammationThe heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetesNonalcoholic Steatohepatitis: A Search for Factual Animal Models.NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease.Acidophil bodies in nonalcoholic steatohepatitis.Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice.Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study.Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats.Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.[Nuclear Her2 expression in hepatocytes in liver disease].Apoptosis and non-alcoholic fatty liver diseases.
P2860
Q24563068-DEA6D72D-81FD-47E7-96D8-B5BD4F85BE49Q30365017-3FDB9110-1E58-4C80-8A0C-5F541A7FE6AEQ33755829-1E9E3F19-C11A-4DE6-88A3-500D88F3AF85Q34252404-21143F1E-BEB8-499C-89CF-296BBB8D9374Q34294773-1AF37DA8-8358-4992-A6BF-9018AFD81926Q34988970-FDDE3737-9C5C-47AD-A9D2-D216303C201BQ35048289-355F7726-4F79-4F1C-8B45-43FE7CD59574Q35612535-01091722-CFC4-47D1-8E47-1269BD98491BQ35931190-97A746D1-E7AB-4B21-9D16-E5209DA0F579Q35984078-7B8CC872-0689-4237-8C36-1C2CBB24A033Q37638658-3FC3B02E-1B75-4009-BE79-13802697B151Q38291587-E586188C-17A3-44D4-8CFD-189325025BD4Q41686499-60BBC000-718F-482F-B62E-F5FA4CE948CBQ42249904-84DBDC4D-ADE5-480F-A337-1D38EE73AC8AQ47150578-E27E76AD-DADD-4CFC-AE66-D2BF625AC613Q50091796-D384ED1E-4CA0-425B-AEE6-C2EECEC41BFBQ55503094-FCC4C48D-2537-4D55-BBE2-F5E90F4F9069
P2860
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
@en
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
@nl
type
label
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
@en
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
@nl
prefLabel
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
@en
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
@nl
P2860
P356
P1476
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
@en
P2093
Mariana Verdelho Machado
P2860
P304
P356
10.1586/EGH.11.16
P577
2011-04-01T00:00:00Z